Buy benzos online

Comment

Author: Admin | 2025-04-28

HomeRexultiGeneric Availability Last updated on Jan 8, 2025.Rexulti is a brand name of brexpiprazole, approved by the FDA in the following formulation(s):REXULTI (brexpiprazole - tablet;oral) Manufacturer: OTSUKA Approval date: July 10, 2015 Strength(s): 0.25MG [RLD], 0.5MG [RLD], 1MG [RLD], 2MG [RLD], 3MG [RLD], 4MG [RLD] Has a generic version of Rexulti been approved?No. There is currently no therapeutically equivalent version of Rexulti available in the United States.Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rexulti. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.See also: Generic Drug FAQ.Related patentsPatents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims. Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereofPatent 10,307,419Issued: June 4, 2019Inventor(s): Inoue YoshiharuAssignee(s): OTSUKA PHARMACEUTICAL CO., LTD.This invention relates to a tablet containing, as an active ingredient, 7-[4-(4-benzo[b]thiophen-4-yl -piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, that has excellent disintegration ability, storage stability and photostability.Patent expiration dates: October 12, 2032✓ Drug product Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereofPatent 10307419*PEIssued: June 4, 2019Inventor(s): Inoue YoshiharuAssignee(s): OTSUKA PHARMACEUTICAL CO., LTD.This invention relates to a tablet containing, as an active ingredient, 7-[4-(4-benzo[b]thiophen-4-yl -piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, that has excellent disintegration ability, storage stability and photostability.Patent expiration dates: April 12, 2033 Patent 7,888,362Patent

Add Comment